Narayanachar Murali, MD
Gastroenterology · Orangeburg, SCNPI 1649241118
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $652 of the $1,029 with a category attached, or 63.4%. Bristol Myers Squibb accounts for 77.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $924 and has fallen 98.9% since, to $10 in 2025. That places this record below the midpoint for gastroenterology clinicians in SC, where the typical reported total is $2,692.
Across 9 payments — averaging $114.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$792
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$131
- Braintree Laboratories, Inc.$80
- Boston Scientific$15
- Phathom Pharmaceuticals, Inc.$10
Across 205 payments — averaging $6609.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$556K
- Gilead$290K
- Eli Lilly$287K
- Bristol Myers Squibb$160K
- AbbVie$50K
- E.r. Squibb & Sons, L.L.C.$13K
What the payments were for
- Travel & lodging$65263%
- Food & beverage$29729%
- Gifts$808%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 3 | $792 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $131 |
| Braintree Laboratories, Inc. | 1 | $80 |
| Boston Scientific | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozanimod$792
How this compares
$1,029 in reported general payments places this provider in the 25th percentile of 259 gastroenterology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 20 | $187,760 |
| Mesalamine | 21 | $5,955 |
| Entecavir | 18 | $1,466 |
| Tenofovir Disoproxil Fumarate | 12 | $1,401 |
| Omeprazole | 21 | $182 |
| Pantoprazole Sodium | 16 | $107 |
| Spironolactone | 12 | $101 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Orangeburg
- Erin ForsterCharleston$788K
- Mark DeleggeCharleston$568K
- Nathan ShoresCharleston$217K
- Andre EaddyGreenville$212K
- Alejandro SuarezCharleston$210K
- Veeral OzaGreenville$199K
- Peter CottonCharleston$193K
- Christina BauerGreenville$179K
- Andrew PearsonMyrtle Beach$166K
- Joseph MeserveColumbia$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.